BioSA, an initiative established by the South Australian Government, is this week opening its Tech Hub - a business incubator designed to facilitate collaborations, knowledge transfer and support for technology companies. [ + ]

AusBiotech is advocating for the Australian Innovation and Manufacturing (AIM) Incentive as an amendment to the current Australian corporate tax regime and seeks case study examples of Australian businesses that would benefit from such an amendment.

A once-a-year treatment with medicines used to treat osteoporosis shows promise for treating osteoarthritis. [ + ]

Australian researchers have found that omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA), long recognised for helping to prevent heart disease, have another beneficial role to play: increasing the chance of paternity success. [ + ]

Patrys (ASX:PAB) CEO and Managing Director Dr Marie Roskrow has tendered her resignation, effective at the end of the year.

Invion (ASX:IVX) may be on the way to reversing the contraindication for nadolol in asthma, if interim results from a phase II trial of INV102 are an indication.

Bionomics (ASX:BNO) is buying Prestwick Chemical, a medicinal chemistry services provider co-located with its France-based CRO business. [ + ]

A national prize and four awards are being offered by the Translation Research Institute to support translational research. [ + ]

As part of the University of Western Australia's (UWA) Raine Visiting Professor Lecture Series, Stephan Schuster is this week presenting a talk titled 'How ethnicity matters for medical genomics'. [ + ]

The 2014 Ig Nobel Prizes were awarded on 18 September at the 24th First Annual Ig Nobel Prize Ceremony, held at Harvard University's Sanders Theatre. [ + ]

This year, Australia stamped its presence on the 2014 BIO International Convention with more than 250 delegates from Australia attending BIO 2014, making Australia the eighth-largest international delegation. Australia's continuing presence at BIO coincides with Australia's growing reputation as one of the world leaders in biotechnology.

Genetic Technologies (ASX:GTG) will sell its Australian genetics testing business to a Primary Health Care subsidiary for $2m. [ + ]

Cartilage plays an active role in the destruction and remodelling of joints in rheumatoid arthritis. [ + ]

Starpharma (ASX:SPL) is conducting an up to $23m placement and plans to use part of the proceeds to help fund clinical trials of VivaGel and DEP docetaxel.

Australia's first team to enter BIOMOD, an undergraduate synthetic biology competition held by Harvard University, is calling for funds to help cover the team's participation in the event. [ + ]